GP(33-41), a 9-aa-long peptide, is the optimal sequence of the GP1 epitope of lymphocytic choriomeningitis virus, and can upregulate H-2D molecules at the RMA-S (Db Kb) cell surface with a SC50 of 344 nM.
体外研究
GP(33-41) sensitizes MC57 and T2-D cells to lysis with ED50s of 0.9±0.6 and 2.5±0.7 nM.
The interaction between T cell receptors (TCR) and peptide-major histocompatibility complex (pMHC) antigens can lead to varying degrees of agonism (T cell activation), or antagonism. The P14 TCR recognises the lymphocytic choriomeningitis virus (LCMV)-derived peptide, GP(33-41) (KAVYNFATC), presents in the context of H-2D.
分子量
226.98
CAS号
161928-86-5
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Please store the product under the recommended conditions in the Certificate of Analysis.